Joël Richard VP, Peptides for Ipsen on Formulation Challenges for Biological Drug Products
Contributor:
Joël Richard
Posted: 02/04/2013 12:00:00 AM EST | 0
Posted: 02/04/2013 12:00:00 AM EST | 0
|
In this industry interview Joël Richard Vice President, Peptides for Ipsen, speaks to Andrea Charles from Pharma IQ, about formulation challenges for biological drug products.
Pharma IQ: Can you briefly explain your current role and responsibilities?
J Richard: I'm presently the Vice-President, Peptides, for Ipsen, which means that I'm leading all ...
-
Clinical Research “Likely to Return to the UK” Following Change in Patent Law -
High-Throughput Screening: Best Practice, Trends and Challenges -
Retention of Talent in the Pharma Industry -
5 Reasons why Effective Pharmaceutical Packaging is Key to the Success for Commercial Product Launches -
Pharmaceutical Jobs Insight -
6 Hot Topics for Disposable Solutions in Biomanufacturing -
Drugs in Sport: How should the Pharma Industry Respond? -
Drug Discovery Partnerships - Challenges and Opportunities -
Pharma Industry Infonugget #5 - How often did companies review their CMO contracts? -
The Top 10 Pinnacle Moments in the Pharma Industry
* = required.
Not a member yet? Sign up
You Should Check Out:
Events of Interest
-
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now -
hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing
March 28, 2012
Register Now -
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches
February 9, 2012
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!